|Rapid Review complete
|Peripheral neuropathic pain in non-diabetic adults either alone or in combination with other medicinal products for pain.
|Rapid review commissioned
|Rapid review completed
|Rapid review outcome
|Full Pharmacoeconomic Evaluation Recommended
The company has not submitted a HTA dossier to the NCPE therefore the cost effectiveness of the technology could not be proven.